Company intelligence / Profile preview

BellBrook Labs

Madison, Wisconsin, United States

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

BellBrook Labs develops high throughput screening assay platforms—primarily the Transcreener® technology—to accelerate enzyme-targeted drug discovery. Their products are widely adopted by major pharmaceutical companies to streamline lead identification and optimization. They do not have clinical results as they do not develop drugs directly.

Modalities: Small moleculeBiologicEnzyme assay
Industry: Drug Discovery Services

Beyond the preview

Go deeper on BellBrook Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BellBrook Labs.

Explore the full profile